KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Average: 2011-2025

Historic Equity Average for Exact Sciences (EXAS) over the last 14 years, with Sep 2025 value amounting to $2.5 billion.

  • Exact Sciences' Equity Average fell 22.37% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 22.37%. This contributed to the annual value of $2.8 billion for FY2024, which is 10.36% down from last year.
  • As of Q3 2025, Exact Sciences' Equity Average stood at $2.5 billion, which was up 2.15% from $2.4 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Equity Average ranged from a high of $3.6 billion in Q2 2021 and a low of $2.4 billion during Q1 2025.
  • For the 3-year period, Exact Sciences' Equity Average averaged around $2.9 billion, with its median value being $3.1 billion (2023).
  • In the last 5 years, Exact Sciences' Equity Average spiked by 49.70% in 2021 and then decreased by 23.56% in 2025.
  • Over the past 5 years, Exact Sciences' Equity Average (Quarterly) stood at $3.4 billion in 2021, then dropped by 10.13% to $3.1 billion in 2022, then climbed by 1.87% to $3.1 billion in 2023, then declined by 10.43% to $2.8 billion in 2024, then fell by 22.37% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q3 2025, $2.4 billion for Q2 2025, and $2.4 billion during Q1 2025.